• News
  • SAN DIEGO
  • Finance

Acadia Pharmaceuticals announces equity financing

Acadia Pharmaceuticals Inc. announced a private placement equity financing and will receive gross proceeds of $86.4 million from the sale of its securities.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Acadia Pharmaceuticals Inc.

Company Website

3911 Sorrento Valley Blvd.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ACAD
18.36
  0.54  
+ 3.03%
1,124,679,000
32.00
11.26

Insider Trade Data

Date Insider Shares Type Value
04/04/2014 Aasen, Thomas H 7,500 Exchange $11,625
04/04/2014 Rasmussen, Torsten 30,000 Exchange $72,075
04/04/2014 Brege, Laura A 14,285 Sell $321,925
04/04/2014 Rasmussen, Torsten 30,000 Exchange $72,075
04/04/2014 Rasmussen, Torsten 30,000 Sell $659,385

Acadia Pharmaceuticals Inc. Executive(s):

Uli Hacksell

  • Chief Executive Officer, President

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!